D. Aarsland, K. Bronnick, G. Alves, O. Tysnes, K. Pedersen et al., The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.8, pp.928-958, 2009.
DOI : 10.1136/jnnp.2008.166959

D. Aarsland, J. Larsen, N. Lim, C. Janvin, K. Karlsen et al., Range of neuropsychiatric disturbances in patients with Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.67, issue.4, pp.492-498, 1999.
DOI : 10.1136/jnnp.67.4.492

F. Ambroggi, A. Ishikawa, H. Fields, and S. Nicola, Basolateral Amygdala Neurons Facilitate Reward-Seeking Behavior by Exciting Nucleus Accumbens Neurons, Neuron, vol.59, issue.4, pp.648-61, 2008.
DOI : 10.1016/j.neuron.2008.07.004

C. Ardouin, I. Ché-reau, P. Llorca, E. Lhommé-e, F. Durif et al., ??valuation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson, Revue Neurologique, vol.165, issue.11, pp.845-56, 2009.
DOI : 10.1016/j.neurol.2009.06.003

C. Ardouin, E. Lhommé-e, S. Thobois, H. Klinger, C. Lagrange et al., Piribedil improves apathy, depression and anxiety in Parkinson's disease, Mov Disord, vol.24, issue.1, p.233, 2009.

C. Ardouin, B. Pillon, E. Peiffer, P. Bejjani, P. Limousin et al., Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients, Annals of Neurology, vol.13, issue.2, pp.217-240, 1999.
DOI : 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z

C. Ardouin, V. Voon, Y. Worbe, N. Abouazar, V. Czernecki et al., Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation, Movement Disorders, vol.22, issue.11, pp.1941-1947, 2006.
DOI : 10.1002/mds.21098

A. Barbeau, Dopa therapy in Parkinsons disease: a critical review of nine years experience, Can Med Assess J, vol.101, pp.791-800, 1969.

P. Barone, A. Antonini, C. Colosimo, R. Marconi, L. Morgante et al., The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease, Movement Disorders, vol.23, issue.11, pp.1641-1650, 2009.
DOI : 10.1002/mds.22643

A. Beck, N. Epstein, G. Brown, and R. Steer, An inventory for measuring clinical anxiety: Psychometric properties., Journal of Consulting and Clinical Psychology, vol.56, issue.6, pp.893-900, 1988.
DOI : 10.1037/0022-006X.56.6.893

A. Beck, R. Steer, and G. Brown, Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatients, Journal of Personality Assessment, vol.57, issue.3, pp.588-97, 1996.
DOI : 10.1016/0272-7358(88)90050-5

B. Bejjani, I. Arnulf, S. Demeret, P. Damier, A. Bonnet et al., Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible?, Annals of Neurology, vol.27, issue.5, pp.655-663, 2000.
DOI : 10.1002/1531-8249(200005)47:5<655::AID-ANA16>3.0.CO;2-#

M. Benoit, P. Koulibaly, O. Migneco, J. Darcourt, D. Pringuey et al., Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis, Psychiatry Research: Neuroimaging, vol.114, issue.2, pp.103-114, 2002.
DOI : 10.1016/S0925-4927(02)00003-3

K. Bhatia and C. Marsden, The behavioural and motor consequences of focal lesions of the basal ganglia in man, Brain, vol.117, issue.4, pp.859-76, 1994.
DOI : 10.1093/brain/117.4.859

K. Black, T. Hershey, J. Hartlein, J. Carl, and J. Perlmutter, Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease, Neuropsychopharmacology, vol.30, issue.3, pp.590-601, 2005.
DOI : 10.1038/sj.npp.1300632

N. Bodi, S. Keri, H. Nagy, A. Moustafa, C. Myers et al., Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients, Brain, vol.132, issue.9, pp.2385-95, 2009.
DOI : 10.1093/brain/awp094

J. Bostwick, K. Hecksel, S. Stevens, J. Bower, and J. Ahlskog, Frequency of New-Onset Pathologic Compulsive Gambling or Hypersexuality After Drug Treatment of Idiopathic Parkinson Disease, Mayo Clinic Proceedings, vol.84, issue.4, pp.310-316, 2009.
DOI : 10.1016/S0025-6196(11)60538-7

J. Brog, A. Salyapongse, A. Deutch, and D. Zahm, The patterns of afferent innervation of the core and shell in the ?Accumbens? part of the rat ventral striatum: Immunohistochemical detection of retrogradely transported fluoro-gold, The Journal of Comparative Neurology, vol.255, issue.2, pp.255-78, 1993.
DOI : 10.1002/cne.903380209

R. Brown and G. Pluck, Negative symptoms: the ???pathology??? of motivation and goal-directed behaviour, Trends in Neurosciences, vol.23, issue.9, pp.412-419, 2000.
DOI : 10.1016/S0166-2236(00)01626-X

L. Castelli, M. Lanotte, M. Zibetti, M. Caglio, L. Rizzi et al., Apathy and verbal fluency in STN-stimulated PD patients, Journal of Neurology, vol.355, issue.9, pp.1238-1281, 2007.
DOI : 10.1007/s00415-006-0510-7

A. Cavanna, S. Servo, F. Monaco, and M. Robertson, The Behavioral Spectrum of Gilles de la Tourette Syndrome, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.21, issue.1, pp.13-23, 2009.
DOI : 10.1176/jnp.2009.21.1.13

K. Chaudhuri, P. Martinez-martin, A. Schapira, F. Stocchi, K. Sethi et al., International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study, Movement Disorders, vol.19, issue.Suppl. 10, pp.916-939, 2006.
DOI : 10.1002/mds.20844

K. Chaudhuri and A. Schapira, Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment, The Lancet Neurology, vol.8, issue.5, pp.464-74, 2009.
DOI : 10.1016/S1474-4422(09)70068-7

R. Cilia, C. Siri, G. Marotta, I. Isaias, D. Gaspari et al., Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease, Archives of Neurology, vol.65, issue.12, pp.1604-1615, 2008.
DOI : 10.1001/archneur.65.12.1604

G. Cotzias, P. Papavasiliou, and R. Gellene, Modification of Parkinsonism ??? Chronic Treatment with L-Dopa, New England Journal of Medicine, vol.280, issue.7, pp.337-382, 1969.
DOI : 10.1056/NEJM196902132800701

V. Czernecki, B. Pillon, J. Houeto, J. Pochon, R. Levy et al., Motivation, reward, and Parkinson's disease: influence of dopatherapy, Neuropsychologia, vol.40, issue.13, pp.2257-67, 2002.
DOI : 10.1016/S0028-3932(02)00108-2

V. Czernecki, B. Pillon, J. Houeto, M. Welter, V. Mesnage et al., Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.6, pp.775-784, 2005.
DOI : 10.1136/jnnp.2003.033258

V. Czernecki, M. Schupbach, S. Yaici, R. Levy, E. Bardinet et al., Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom, Movement Disorders, vol.172, issue.7, pp.964-973, 2008.
DOI : 10.1002/mds.21949

URL : https://hal.archives-ouvertes.fr/hal-00805452

D. Chiara, G. Imperato, and A. , Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats., Proceedings of the National Academy of Sciences, vol.85, issue.14, pp.5274-5282, 1988.
DOI : 10.1073/pnas.85.14.5274

M. Dodd, K. Klos, J. Bower, Y. Geda, K. Josephs et al., Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease, Archives of Neurology, vol.62, issue.9, pp.1377-81, 2005.
DOI : 10.1001/archneur.62.9.noc50009

D. Drapier, S. Drapier, P. Sauleau, C. Haegelen, R. S. Biseul et al., Does subthalamic nucleus stimulation induce apathy in Parkinson???s disease?, Journal of Neurology, vol.125, issue.Pt 10, pp.1083-91, 2006.
DOI : 10.1007/s00415-006-0177-0

W. Drevets, C. Gauthier, J. Price, D. Kupfer, P. Kinahan et al., Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria, Biological Psychiatry, vol.49, issue.2, pp.81-96, 2001.
DOI : 10.1016/S0006-3223(00)01038-6

K. Dujardin, P. Sockeel, D. Devos, M. Delliaux, P. Krystkowiak et al., Characteristics of apathy in Parkinson's disease, Movement Disorders, vol.14, issue.6, pp.778-84, 2007.
DOI : 10.1002/mds.21316

A. Evans and A. Lees, Dopamine dysregulation syndrome in Parkinson??s disease, Current Opinion in Neurology, vol.17, issue.4, pp.393-401, 2004.
DOI : 10.1097/01.wco.0000137528.23126.41

A. Evans, N. Pavese, A. Lawrence, Y. Tai, S. Appel et al., Compulsive drug use linked to sensitized ventral striatal dopamine transmission, Annals of Neurology, vol.8, issue.5, pp.852-860, 2006.
DOI : 10.1002/ana.20822

S. Fahn, D. Oakes, I. Shoulson, K. Kieburtz, A. Rudolph et al., Levodopa and the progression of Parkinson's disease, N Engl J Med, vol.351, pp.2547-2556, 2004.

J. Fields and A. Troster, Cognitive Outcomes after Deep Brain Stimulation for Parkinson's Disease: A Review of Initial Studies and Recommendations for Future Research, Brain and Cognition, vol.42, issue.2, pp.268-93, 2000.
DOI : 10.1006/brcg.1999.1104

S. Fox and A. Lang, Levodopa-related motor complications-Phenomenology, Movement Disorders, vol.21, issue.S3, pp.509-523, 2008.
DOI : 10.1002/mds.22021

K. Friston, A. Holmes, K. Worsley, J. Poline, C. Frith et al., Statistical parametric maps in functional imaging: A general linear approach, Human Brain Mapping, vol.26, issue.4, pp.189-210, 1995.
DOI : 10.1002/hbm.460020402

A. Funkiewiez, C. Ardouin, E. Caputo, P. Krack, V. Fraix et al., Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.75, issue.6, pp.834-843, 2004.
DOI : 10.1136/jnnp.2002.009803

A. Funkiewiez, C. Ardouin, P. Krack, V. Fraix, N. Vanblercom et al., Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease, Movement Disorders, vol.15, issue.5, pp.524-554, 2003.
DOI : 10.1002/mds.10441

A. Gjedde, D. Wong, P. Rosa-neto, and P. Cumming, Mapping Neuroreceptors at work: on the Definition and Interpretation of Binding Potentials after 20 years of Progress, Int Rev Neurobiol, vol.63, pp.1-20, 2005.
DOI : 10.1016/S0074-7742(05)63001-2

C. Goetz, B. Tilley, S. Shaftman, G. Stebbins, S. Fahn et al., Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results, Movement Disorders, vol.10, issue.15, pp.2129-70, 2008.
DOI : 10.1002/mds.22340

J. Guelfi, . Vfr, and P. Caille, The Norris VAS and the ADA inventory: a factor analysis in outpatients, Proceedings of the VIII World Congress of Psychiatry, p.484, 1989.

O. Guillin, J. Diaz, P. Carroll, N. Griffon, J. Schwartz et al., BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization, Nature, vol.411, issue.6833, pp.86-95, 2001.
DOI : 10.1038/35075076

V. Holthoff, B. Beuthien-baumann, E. Kalbe, S. Ludecke, O. Lenz et al., Regional cerebral metabolism in early Alzheimer???s disease with clinically significant apathy or depression, Biological Psychiatry, vol.57, issue.4, pp.412-433, 2005.
DOI : 10.1016/j.biopsych.2004.11.035

J. Houeto, V. Mesnage, L. Mallet, B. Pillon, M. Gargiulo et al., Behavioural disorders, Parkinson's disease and subthalamic stimulation, Journal of Neurology, Neurosurgery & Psychiatry, vol.72, issue.6, pp.701-708, 2002.
DOI : 10.1136/jnnp.72.6.701

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737905

V. Isella, P. Melzi, M. Grimaldi, R. Piolti, C. Ferrarese et al., Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease, Movement Disorders, vol.84, issue.2, pp.366-71, 2002.
DOI : 10.1002/mds.10041

J. Agid, F. Agid, and Y. , Is the mesocortical dopaminergic system involved in Parkinson disease?, Neurology, vol.30, issue.12, pp.1326-1356, 1980.
DOI : 10.1212/WNL.30.12.1326

T. Kienast, A. Hariri, F. Schlagenhauf, J. Wrase, P. Sterzer et al., Dopamine in amygdala gates limbic processing of aversive stimuli in humans, Nature Neuroscience, vol.22, issue.12, pp.1381-1383, 2008.
DOI : 10.1016/j.neuroimage.2007.11.023

L. Kirsch-darrow, H. Fernandez, M. Marsiske, M. Okun, and D. Bowers, Dissociating apathy and depression in Parkinson disease, Neurology, vol.67, issue.1, pp.33-41, 2006.
DOI : 10.1212/01.wnl.0000230572.07791.22

G. Kleiner-fisman, J. Herzog, D. Fisman, F. Tamma, K. Lyons et al., Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes, Movement Disorders, vol.70, issue.S14, pp.290-304, 2006.
DOI : 10.1002/mds.20962

P. Krack, A. Batir, N. Van-blercom, S. Chabardes, V. Fraix et al., Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease, New England Journal of Medicine, vol.349, issue.20, pp.1925-1959, 2003.
DOI : 10.1056/NEJMoa035275

P. Krack, R. Kumar, C. Ardouin, L. Dowsey, P. Mcvicker et al., Mirthful laughter induced by subthalamic nucleus stimulation, Movement Disorders, vol.353, issue.Suppl, pp.867-75, 2001.
DOI : 10.1002/mds.1174

P. Krack, P. Pollak, P. Limousin, A. Benazzouz, G. Deuschl et al., From off-period dystonia to peak-dose chorea: The clinical spectrum of varying subthalamic nucleus activity, Brain, vol.122, issue.6, pp.1133-1179, 1999.
DOI : 10.1093/brain/122.6.1133

P. Krack, P. Pollak, P. Limousin, D. Hoffmann, J. Xie et al., Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease, Brain, vol.121, issue.3, pp.451-458, 1998.
DOI : 10.1093/brain/121.3.451

D. Laplane, M. Baulac, D. Widlocher, and B. Dubois, Pure psychic akinesia with bilateral lesions of basal ganglia., Journal of Neurology, Neurosurgery & Psychiatry, vol.47, issue.4, pp.377-85, 1984.
DOI : 10.1136/jnnp.47.4.377

A. Lawrence, A. Evans, and A. Lees, Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?, The Lancet Neurology, vol.2, issue.10, pp.595-604, 2003.
DOI : 10.1016/S1474-4422(03)00529-5

L. Jeune, F. Drapier, D. Bourguignon, A. Peron, J. Mesbah et al., Subthalamic nucleus stimulation in Parkinson disease induces apathy: A PET study, Neurology, vol.73, issue.21, pp.1746-51, 2009.
DOI : 10.1212/WNL.0b013e3181c34b34

L. Jeune, F. Peron, J. Biseul, I. Fournier, S. Sauleau et al., Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a pet study, Brain, vol.131, issue.6, pp.1599-608, 2008.
DOI : 10.1093/brain/awn084

J. Ledoux, The emotional brain, fear, and the amygdala, Cellular and Molecular Neurobiology, vol.23, issue.4/5, pp.727-765, 2003.
DOI : 10.1023/A:1025048802629

A. Lees, The Parkinson chimera, Neurology, vol.72, issue.Issue 7, Supplement 2, pp.2-11, 2009.
DOI : 10.1212/WNL.0b013e318198daec

M. Lemke, H. Brecht, J. Koester, P. Kraus, and H. Reichmann, Anhedonia, Depression, and Motor Functioning in Parkinson???s Disease During Treatment With Pramipexole, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.17, issue.2, pp.214-234, 2005.
DOI : 10.1176/jnp.17.2.214

M. Levy, J. Cummings, L. Fairnbanks, D. Masterman, B. Miller et al., Apathy Is Not Depression, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.10, issue.3, pp.314-323, 1998.
DOI : 10.1176/jnp.10.3.314

R. Levy and B. Dubois, Apathy and the Functional Anatomy of the Prefrontal Cortex-Basal Ganglia Circuits, Cerebral Cortex, vol.16, issue.7, pp.916-944, 2006.
DOI : 10.1093/cercor/bhj043

S. Lim, O. Sullivan, S. Kotschet, K. Gallagher, D. Lacey et al., Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson???s disease, Journal of Clinical Neuroscience, vol.16, issue.9, pp.1148-52, 2009.
DOI : 10.1016/j.jocn.2008.12.010

M. Liotti, H. Mayberg, S. Brannan, S. Mcginnis, P. Jerabek et al., Differential limbic???cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders, Biological Psychiatry, vol.48, issue.1, pp.30-42, 2000.
DOI : 10.1016/S0006-3223(00)00874-X

J. Logan, J. Fowler, N. Volkow, G. Wang, Y. Ding et al., Distribution Volume Ratios Without Blood Sampling from Graphical Analysis of PET Data, Journal of Cerebral Blood Flow & Metabolism, vol.226, pp.834-874, 1996.
DOI : 10.1097/00004647-199609000-00008

R. Maddock, A. Garrett, and M. Buonocore, Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task, Human Brain Mapping, vol.156, issue.1, pp.30-41, 2003.
DOI : 10.1002/hbm.10075

L. Mallet, M. Schupbach, N. Diaye, K. , R. P. Bardinet et al., Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior, Proceedings of the National Academy of Sciences, vol.104, issue.25, pp.10661-10667, 2007.
DOI : 10.1073/pnas.0610849104

R. Maricle, J. Nutt, and J. Carter, Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: Preliminary findings, Movement Disorders, vol.87, issue.3, pp.329-361, 1995.
DOI : 10.1002/mds.870100316

R. Marin, Apathy: a neuropsychiatric syndrome, J Neuropsychiatry Clin Neurosci, vol.3, pp.243-54, 1991.

H. Mayberg, S. Brannan, J. Tekell, J. Silva, R. Mahurin et al., Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response, Biological Psychiatry, vol.48, issue.8, pp.830-873, 2000.
DOI : 10.1016/S0006-3223(00)01036-2

M. Menza, L. Golbe, R. Cody, and N. Forman, Dopamine-related personality traits in Parkinson's disease, Neurology, vol.43, issue.3, Part 1, pp.505-513, 1993.
DOI : 10.1212/WNL.43.3_Part_1.505

M. Menza, M. Mark, D. Burn, and D. Brooks, Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease, J Neuropsychiatry Clin Neurosci, vol.7, pp.176-185, 1995.

O. Migneco, M. Benoit, P. Koulibaly, I. Dygai, C. Bertogliati et al., Perfusion Brain SPECT and Statistical Parametric Mapping Analysis Indicate That Apathy Is a Cingulate Syndrome: A Study in Alzheimer's Disease and Nondemented Patients, NeuroImage, vol.13, issue.5, pp.896-902, 2001.
DOI : 10.1006/nimg.2000.0741

E. Moro, R. Esselink, A. Benabid, and P. Pollak, Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation, Brain, vol.125, issue.11, pp.2408-2425, 2002.
DOI : 10.1093/brain/awf249

F. Naville, Etudes sur les complications et les sé quelles mentales de l'encé phalite e ´ pidé mique. La bradyphrenie, Encephale, vol.17, pp.369-75, 1922.

E. Nestler, W. Carlezon, and . Jr, The Mesolimbic Dopamine Reward Circuit in Depression, Biological Psychiatry, vol.59, issue.12, pp.1151-1160, 2006.
DOI : 10.1016/j.biopsych.2005.09.018

H. Nissenbaum, N. Quinn, R. Brown, B. Toone, A. Gotham et al., Mood swings associated with the ???on???off??? phenomenon in Parkinson's disease, Psychological Medicine, vol.107, issue.04, pp.899-904, 1987.
DOI : 10.1038/229135a0

H. Norris, The action of sedatives on brain stem oculomotor systems in man, Neuropharmacology, vol.10, issue.2, pp.181-91, 1971.
DOI : 10.1016/0028-3908(71)90039-6

J. Nutt, J. Carter, and N. Carlson, Effects of Methylphenidate on Response to Oral Levodopa, Archives of Neurology, vol.64, issue.3, pp.319-342, 2007.
DOI : 10.1001/archneur.64.3.319

K. Pedersen, G. Alves, K. Bronnick, D. Aarsland, O. Tysnes et al., Apathy in drug-na??ve patients with incident Parkinson???s disease: the Norwegian ParkWest study, Journal of Neurology, vol.67, issue.2, pp.217-240, 2010.
DOI : 10.1007/s00415-009-5297-x

K. Pedersen, J. Larsen, G. Alves, and D. Aarsland, Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study, Parkinsonism & Related Disorders, vol.15, issue.4, pp.295-304, 2009.
DOI : 10.1016/j.parkreldis.2008.07.006

F. Peters, D. Perani, K. Herholz, V. Holthoff, B. Beuthien-baumann et al., Orbitofrontal Dysfunction Related to Both Apathy and Disinhibition in Frontotemporal Dementia, Dementia and Geriatric Cognitive Disorders, vol.21, issue.5-6, pp.373-382, 2006.
DOI : 10.1159/000091898

S. Rahman, H. Griffin, N. Quinn, and M. Jahanshahi, Quality of life in Parkinson's disease: The relative importance of the symptoms, Movement Disorders, vol.31, issue.10, pp.1428-1462, 2008.
DOI : 10.1002/mds.21667

P. Remy, M. Doder, A. Lees, N. Turjanski, and D. Brooks, Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system, Brain, vol.128, issue.6, pp.1314-1336, 2005.
DOI : 10.1093/brain/awh445

M. Rodriguez-oroz, M. Jahanshahi, P. Krack, I. Litvan, R. Macias et al., Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms, The Lancet Neurology, vol.8, issue.12, pp.1128-1167, 2009.
DOI : 10.1016/S1474-4422(09)70293-5

L. Romito, M. Raja, D. A. Contarino, M. Bentivoglio, A. Barbier et al., Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease, Movement Disorders, vol.42, issue.6, pp.1371-1375, 2002.
DOI : 10.1002/mds.10265

J. Saint-cyr, L. Tré-panier, R. Kumar, A. Lozano, and A. Lang, Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease, Brain, vol.123, issue.10, pp.2091-108, 2000.
DOI : 10.1093/brain/123.10.2091

F. Schlagenhauf, G. Juckel, M. Koslowski, T. Kahnt, B. Knutson et al., Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine, Psychopharmacology, vol.36, issue.4, pp.673-84, 2008.
DOI : 10.1007/s00213-007-1016-4

L. Schmidt, B. Arc, G. Lafargue, D. Galanaud, V. Czernecki et al., Disconnecting force from money: effects of basal ganglia damage on incentive motivation, Brain, vol.131, issue.5, pp.1303-1313, 2008.
DOI : 10.1093/brain/awn045

URL : https://hal.archives-ouvertes.fr/hal-00333398

W. Schultz, Predictive reward signal of dopamine neurons, J Neurophysiol, vol.80, pp.1-27, 1998.

M. Schweri, P. Skolnick, M. Rafferty, K. Rice, A. Janowsky et al., H]Threo-(??)-Methylphenidate Binding to 3,4-Dihydroxyphenylethylamine Uptake Sites in Corpus Striatum: Correlation with the Stimulant Properties of Ritalinic Acid Esters, Journal of Neurochemistry, vol.Vol. II, issue.4, pp.1062-70, 1985.
DOI : 10.1111/j.1471-4159.1985.tb05524.x

M. Shiba, J. Bower, D. Maraganore, S. Mcdonnell, B. Peterson et al., Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study, Movement Disorders, vol.78, issue.4, pp.669-77, 2000.
DOI : 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5

J. Simpson, . Jr, W. Drevets, A. Snyder, D. Gusnard et al., Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety, Proceedings of the National Academy of Sciences, vol.98, issue.2, pp.688-93, 2001.
DOI : 10.1073/pnas.98.2.688

H. Smeding, A. Goudriaan, E. Foncke, P. Schuurman, J. Speelman et al., Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.5, pp.517-526, 2007.
DOI : 10.1136/jnnp.2006.102061

H. Smeding, J. Speelman, M. Koning-haanstra, P. Schuurman, P. Nijssen et al., Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study, Neurology, vol.66, issue.12, pp.1830-1836, 2006.
DOI : 10.1212/01.wnl.0000234881.77830.66

M. Stacy, A. Bowron, M. Guttman, R. Hauser, K. Hughes et al., Identification of motor and nonmotor wearing-off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment, Movement Disorders, vol.18, issue.6, pp.726-759, 2005.
DOI : 10.1002/mds.20383

M. Stacy, H. Murck, and K. Kroenke, Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.34, issue.1, pp.57-61, 2010.
DOI : 10.1016/j.pnpbp.2009.09.023

S. Starkstein and A. Leentjens, The nosological position of apathy in clinical practice, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.10, pp.1088-92, 2008.
DOI : 10.1136/jnnp.2007.136895

S. Starkstein, H. Mayberg, T. Preziosi, P. Andrezejewski, R. Leiguarda et al., Reliability, validity, and clinical correlates of apathy in Parkinson's disease, J Neuropsychiatry Clin Neurosci, vol.4, pp.134-143, 1992.

S. Starkstein, M. Merello, J. R. Brockman, S. Bruce, D. Power et al., The syndromal validity and nosological position of apathy in Parkinson's disease, Movement Disorders, vol.23, issue.8, pp.1211-1217, 2009.
DOI : 10.1002/mds.22577

T. Steeves, J. Miyasaki, M. Zurowski, A. Lang, G. Pellecchia et al., Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study, Brain, vol.132, issue.5, pp.1376-85, 2009.
DOI : 10.1093/brain/awp054

Y. Temel, S. Tan, R. Vlamings, T. Sesia, L. Lim et al., Cognitive and limbic effects of deep brain stimulation in preclinical studies, Frontiers in Bioscience, vol.Volume, issue.14, pp.1891-901, 2009.
DOI : 10.2741/3349

URL : https://hal.archives-ouvertes.fr/hal-01384830

S. Thobois, Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: A review of the literature, Clinical Therapeutics, vol.28, issue.1, pp.1-12, 2006.
DOI : 10.1016/j.clinthera.2005.12.003

S. Thobois, F. Vingerhoets, V. Fraix, X. Brustolin, J. Mollion et al., Role of the dopamainergic treatment in dopamine receptor downregulation in advanced Parkinson's disease: a C-raclopride PET study, Arch Neurol, vol.61, p.1709, 2004.

E. Tolosa, C. Gaig, J. Santamaria, and Y. Compta, Diagnosis and the premotor phase of Parkinson disease, Neurology, vol.72, issue.Issue 7, Supplement 2, pp.12-20, 2009.
DOI : 10.1212/WNL.0b013e318198db11

R. Tomer and J. Aharon-peretz, Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency, Journal of Neurology, Neurosurgery & Psychiatry, vol.75, issue.7
DOI : 10.1136/jnnp.2003.024885

A. Troster, Neuropsychology of deep brain stimulation in neurology and psychiatry, Frontiers in Bioscience, vol.Volume, issue.14, pp.1857-79, 2009.
DOI : 10.2741/3347

M. Ulla, S. Thobois, J. Lemaire, A. Schmitt, P. Derost et al., Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.12, pp.1363-1369, 2006.
DOI : 10.1136/jnnp.2006.096628

P. Vezina and M. Leyton, Conditioned cues and the expression of stimulant sensitization in animals and humans, Neuropharmacology, vol.56, pp.160-168, 2009.
DOI : 10.1016/j.neuropharm.2008.06.070

V. Villemagne, D. Wong, F. Yokoi, S. M. Rice, K. Matecka et al., GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [11C]raclopride continuous infusion PET scans, Synapse, vol.20, issue.4, pp.268-73, 1999.
DOI : 10.1002/(SICI)1098-2396(19990915)33:4<268::AID-SYN3>3.0.CO;2-W

B. Vogt, P. Hof, and L. Vogt, Cyngulate gyrus, The human nervous system, pp.915-964, 2003.

N. Volkow, J. Fowler, G. Wang, R. Baler, and F. Telang, Imaging dopamine's role in drug abuse and addiction, Neuropharmacology, vol.56, pp.3-8, 2009.
DOI : 10.1016/j.neuropharm.2008.05.022

N. Volkow, G. Wang, J. Fowler, S. Gatley, J. Logan et al., Dopamine Transporter Occupancies in the Human Brain Induced by Therapeutic Doses of Oral Methylphenidate, American Journal of Psychiatry, vol.155, issue.10, pp.1325-1356, 1998.
DOI : 10.1176/ajp.155.10.1325

V. Voon, P. Fernagut, J. Wickens, C. Baunez, M. Rodriguez et al., Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders, The Lancet Neurology, vol.8, issue.12, pp.1140-1149, 2009.
DOI : 10.1016/S1474-4422(09)70287-X

V. Voon, P. Krack, A. Lang, A. Lozano, K. Dujardin et al., A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease, Brain, vol.131, issue.10, pp.2720-2728, 2008.
DOI : 10.1093/brain/awn214

V. Voon, C. Kubu, P. Krack, J. Houeto, and A. Troster, Deep brain stimulation: Neuropsychological and neuropsychiatric issues, Movement Disorders, vol.43, issue.S14, pp.305-332, 2006.
DOI : 10.1002/mds.20963

URL : https://hal.archives-ouvertes.fr/inserm-00391634

D. Weintraub, Dopamine and impulse control disorders in Parkinson's disease, Annals of Neurology, vol.164, issue.suppl 9, pp.93-100, 2008.
DOI : 10.1002/ana.21454

R. Wise, Roles for nigrostriatal???not just mesocorticolimbic???dopamine in reward and addiction, Trends in Neurosciences, vol.32, issue.10, pp.517-541, 2009.
DOI : 10.1016/j.tins.2009.06.004

T. Witjas, C. Baunez, J. Henry, M. Delfini, J. Regis et al., Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation, Movement Disorders, vol.345, issue.8, pp.1052-1057, 2005.
DOI : 10.1002/mds.20501

T. Witjas, E. Kaphan, J. Azulay, O. Blin, M. Ceccaldi et al., Nonmotor fluctuations in Parkinson's disease: Frequent and disabling, Neurology, vol.59, issue.3, pp.408-421, 2002.
DOI : 10.1212/WNL.59.3.408

K. Witt, C. Daniels, J. Reiff, P. Krack, J. Volkmann et al., Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study, The Lancet Neurology, vol.7, issue.7, pp.605-619, 2008.
DOI : 10.1016/S1474-4422(08)70114-5

J. Wu, K. Bell, A. Najafi, C. Widmark, D. Keator et al., Decreasing Striatal 6-FDOPA Uptake with Increasing Duration of Cocaine Withdrawal, Neuropsychopharmacology, vol.17, issue.6, pp.402-411, 1997.
DOI : 10.1016/S0893-133X(97)00089-4

M. Yahr, R. Duvoisin, M. Schear, E. Barrett, and M. Hoehn, Treatment of Parkinsonism With Levodopa, Archives of Neurology, vol.21, issue.4, pp.343-54, 1969.
DOI : 10.1001/archneur.1969.00480160015001